Pfizer Inc. (PFE)
27.65
+0.55
(+2.03%)
USD |
NYSE |
Feb 27, 16:00
27.55
-0.10
(-0.36%)
Pre-Market: 20:00
Pfizer Research and Development Expense (TTM) : 10.25B for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amgen, Inc. | 7.281B |
| Gilead Sciences, Inc. | 5.688B |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| CorMedix, Inc. | 12.46M |
| Moderna, Inc. | 2.917B |